These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 30693828)
1. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China. Su M; Gao YJ; Pan C; Chen J; Tang JY Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828 [TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540 [TBL] [Abstract][Full Text] [Related]
3. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S; Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis]. Wu FF; Gao YJ; Pan C; Chen J; Tang JY Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076 [TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases. Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539 [TBL] [Abstract][Full Text] [Related]
6. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251 [TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020. Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688 [TBL] [Abstract][Full Text] [Related]
9. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045 [TBL] [Abstract][Full Text] [Related]
10. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution. Davidson L; McComb JG; Bowen I; Krieger MD J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762 [TBL] [Abstract][Full Text] [Related]
11. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases. Esmaili N; Harris GJ Ophthalmic Plast Reconstr Surg; 2016; 32(1):28-34. PubMed ID: 25689784 [TBL] [Abstract][Full Text] [Related]
13. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S; Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933 [TBL] [Abstract][Full Text] [Related]
14. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348 [TBL] [Abstract][Full Text] [Related]
15. Does adjunctive chemotherapy reduce remission rates compared to cortisone alone in unifocal or multifocal histiocytosis of bone? Baptista AM; Camargo AF; de Camargo OP; Odone Filho V; Cassone AE Clin Orthop Relat Res; 2012 Mar; 470(3):663-9. PubMed ID: 22052526 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol]. Huang JB; Xue HM; Chen YY; Huang K Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709 [TBL] [Abstract][Full Text] [Related]
17. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis. Minkov M; Pötschger U; Thacker N; Astigarraga I; Braier J; Donadieu J; Henter JI; Lehrnbecher T; Rodriguez-Galindo C; Sieni E; Nanduri V; van den Bos C; Abla O; J Pediatr; 2021 Oct; 237():65-70.e3. PubMed ID: 34146548 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution. Kamath S; Arkader A; Jubran RF J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center. Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]